Business Overview
Sintetica B2B/B2C.
Dual distribution model
Direct sales to hospitals: distribution in Switzerland, Germany and Austria.
Sales through partners: license agreements with top-tier partners in 50+ countries.
Sintetica is a fast-growing speciality pharma company fully integrated from R&D and production to distribution.
Breakdown by Geography
2024
RoW | 18%
Switzerland | 32%
Germany & Austria | 25%
US | 25%
RoW breakdown
2024
Outside EU | 34%
EU | 66%
Breakdown by Channel
2024
B2B | 41%
B2C | 59%
Breakdown by Therapeutic Area
2024
Neuromodulation | 9%
Emergency & Intensive care | 45%
Anaesthesia | 24%
Analgesics and other | 22%